HUP0200232A2 - Phenylenediamine group and heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses their use and pharmaceutical compositions containing them - Google Patents

Phenylenediamine group and heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses their use and pharmaceutical compositions containing them

Info

Publication number
HUP0200232A2
HUP0200232A2 HU0200232A HUP0200232A HUP0200232A2 HU P0200232 A2 HUP0200232 A2 HU P0200232A2 HU 0200232 A HU0200232 A HU 0200232A HU P0200232 A HUP0200232 A HU P0200232A HU P0200232 A2 HUP0200232 A2 HU P0200232A2
Authority
HU
Hungary
Prior art keywords
alkyl
group
compounds
virus
perhaloalkyl
Prior art date
Application number
HU0200232A
Other languages
Hungarian (hu)
Inventor
Jonathan David Bloom
Kevin Joseph Curran
Martin Joseph Digrandi
Russell George Dushin
Thomas Richard Jones
Stanley Albert Lang
Bryan Mark O'hara
Adma Antonia Ross
Eugene Anthony Terefenko
Original Assignee
American Home Products Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Co. filed Critical American Home Products Co.
Publication of HUP0200232A2 publication Critical patent/HUP0200232A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Abstract

A találmány (I) általános képletű vegyületekre és gyógyászatilagelfogadható sóikra vonatkozik, ahol R1-R5 jelentése egymástólfüggetlenül hidrogénatom, alkil-, alkenil-, alkinil-,perhalogénalkil-, cikloalkil-, heterocikloalkil-, aril-,heteroarilcsoport, halogénatom, ciano-, nitrocsoport, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) vagy W-Y-(CH2)n-Z általános képletű csoport R6 és R7 jelentése egymástólfüggetlenül hidrogénatom, alkil-, perhalogénalkil-, vagy arilcsoport;R8 jelentése hidrogénatom, alkil-, perhalogénalkil-, cikloalkil-,heterocikloalkil-, aril-, heteroarilcsoport, vagy R7 és R8 együtt 3-7tagú heterocikloalkilcsoportot alkothat; W jelentése oxigénatom, -NR6általános képletű csoport, vagy hiányzik; Y jelentése -(CO)- vagy -(CO2)-, vagy hiányzik; Z jelentése alkil-, cianocsoport, -CO2R6, -COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6,SR6N(R7R8), -N(R7R8) általános képletű csoport vagy fenilcsoport; Gjelentése monociklusos heteroarilcsoport; X jelentése vegyértékkötés,-NH, alkil-, alkenil-, alkoxi-, alkil-tio-, alkil-aminocsoport vagy(CH)J általános képletű csoport; J jelentése alkil-, cikloalkil-,fenil- vagy benzilcsoport; és n értéke 1-6. A vegyületek gátoljákés/vagy gyógyítják a herpesz vírusok, például a humáncitomegalovírusok, herpesz szimplex vírusok, Epstein-Barr vírus,varicella-zoster vírus, humán herpesz vírus-6 és -7 és a Kaposiherpesz vírus által okozott betegségeket. A találmány a vegyületekettartalmazó gyógyszerkészítményekre és a vegyületek alkalmazására isvonatkozik. ÓThe invention relates to compounds of general formula (I) and their pharmaceutically acceptable salts, where R1-R5 are independently hydrogen, alkyl, alkenyl, alkynyl, perhaloalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halogen, cyano, nitro . alkyl, perhaloalkyl, or aryl group; R8 is a hydrogen atom, alkyl, perhaloalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl group, or R7 and R8 together can form a 3- to 7-membered heterocycloalkyl group; W is an oxygen atom, a group of general formula -NR6, or is absent; Y is -(CO)- or -(CO2)- or absent; Z is alkyl, cyano, -CO2R6, -COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) or phenyl; G represents a monocyclic heteroaryl group; X is a valence bond, -NH, alkyl, alkenyl, alkoxy, alkylthio, alkylamino or (CH)J; J is alkyl, cycloalkyl, phenyl or benzyl; and n is 1-6. The compounds inhibit and/or cure diseases caused by herpes viruses such as human cytomegalovirus, herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, human herpes virus-6 and -7 and Kaposi's herpes virus. The invention also relates to pharmaceutical preparations containing the compounds and to the use of the compounds. HE

HU0200232A 1998-12-09 1999-12-06 Phenylenediamine group and heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses their use and pharmaceutical compositions containing them HUP0200232A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20855998A 1998-12-09 1998-12-09

Publications (1)

Publication Number Publication Date
HUP0200232A2 true HUP0200232A2 (en) 2002-05-29

Family

ID=22775044

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200232A HUP0200232A2 (en) 1998-12-09 1999-12-06 Phenylenediamine group and heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses their use and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (1) EP1144397A3 (en)
JP (1) JP2002531554A (en)
CN (1) CN1348446A (en)
AU (1) AU1934700A (en)
BG (1) BG105581A (en)
BR (1) BR9916046A (en)
CA (1) CA2350767A1 (en)
CZ (1) CZ20011956A3 (en)
EA (1) EA200100631A1 (en)
HU (1) HUP0200232A2 (en)
ID (1) ID30158A (en)
IL (1) IL143182A0 (en)
NO (1) NO20012832L (en)
PL (1) PL349217A1 (en)
SK (1) SK7682001A3 (en)
TR (1) TR200101664T2 (en)
WO (1) WO2000034258A2 (en)
ZA (1) ZA200104377B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
US6376515B2 (en) 2000-02-29 2002-04-23 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor Xa
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
PT2404906E (en) 2006-11-02 2015-11-02 Millennium Pharm Inc Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
US9334249B2 (en) 2012-11-03 2016-05-10 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
JP6482466B2 (en) * 2012-11-03 2019-03-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cytomegalovirus inhibitors
CN110565100B (en) * 2019-07-12 2021-05-07 西北工业大学 Cobaltocene cation-based corrosion inhibitor and preparation method and use method thereof
WO2023011574A1 (en) 2021-08-05 2023-02-09 浙江海正药业股份有限公司 Aromatic acetylene derivative, and preparation method therefor and use thereof
WO2023088718A1 (en) 2021-11-19 2023-05-25 Basf Se Bicyclic compounds for the control of invertebrate pests
CN115433093A (en) * 2022-09-26 2022-12-06 无锡双启科技有限公司 Preparation method of 3-chloro-4-trifluoromethylaniline
CN115710190A (en) * 2022-11-16 2023-02-24 常州佳德医药科技有限公司 4-methoxy-2-amino-N, N-dimethylaniline, preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191292T3 (en) * 1997-04-10 2003-09-01 Upjohn Co POLYAROMATIC ANTIVIRAL COMPOUNDS.

Also Published As

Publication number Publication date
NO20012832L (en) 2001-08-07
PL349217A1 (en) 2002-07-01
EA200100631A1 (en) 2002-02-28
CA2350767A1 (en) 2000-06-15
TR200101664T2 (en) 2002-03-21
EP1144397A2 (en) 2001-10-17
CN1348446A (en) 2002-05-08
WO2000034258A2 (en) 2000-06-15
NO20012832D0 (en) 2001-06-08
BG105581A (en) 2001-12-31
SK7682001A3 (en) 2002-07-02
ZA200104377B (en) 2002-12-20
AU1934700A (en) 2000-06-26
WO2000034258A3 (en) 2001-11-29
IL143182A0 (en) 2002-04-21
BR9916046A (en) 2001-10-02
EP1144397A3 (en) 2002-09-11
JP2002531554A (en) 2002-09-24
CZ20011956A3 (en) 2001-10-17
ID30158A (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU556150B2 (en) Dihydropyridine derivatives
HUP0200232A2 (en) Phenylenediamine group and heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses their use and pharmaceutical compositions containing them
EP1035123A4 (en) Novel heterocyclic compounds
DE69334250D1 (en) Methods and intermediates for the preparation of retroviral protease inhibitors
EP0368640A3 (en) Heterocyclic compounds
NO162284C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SPIRO (4 (3 + N)) - 2-AZA-ALKAN-3-CARBOXYLIC ACID DERIVATIVES.
ES2123652T3 (en) 7- (2-AMINOETIL) -BENZOTIAZOLONAS.
DK197786D0 (en) N-SUBSTITUTED 2-AMINOTHIAZOLES, PROCEDURES FOR THEIR PREPARATION AND PREPARATIONS CONTAINING THEM
NO861442L (en) SUBSTITUTED N - ((4-PIPERIDINYL) ALKYL)) BICYCLICALLY CONDENSED OKSAZO AND THIAZOLAMINES.
WO2000034237A3 (en) Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
HUP0203405A2 (en) A substituted phenylenediamine group and heterocyclic carboxamide group containing thiourea derivatives inhibitors of herpes viruses, pharmaceutical compositions containing them and their use
HUP0104763A2 (en) Thiourea inhibitors of herpes viruses
HUP0104492A2 (en) Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
HUP0104758A2 (en) Thiourea inhibitors of herpes viruses and pharmaceutical compositions containing them
GB2023137A (en) Derivatives of cyclohexene-1,2- dicarboxylic acid diamide and the herbicidal compositions containing them
EA200100635A1 (en) DERIVATIVES OF THIOMOCHEVIA AS HERPES VIRUS INHIBITORS
ATE56967T1 (en) AMIDE DERIVATIVES.
NO165801C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-ACYLAMINOMETHYLIMIDAZO- (1,2-A) -KINOLINES.